Testing positive for covid again, possible rebound after taking paxlovid. Sore throat, congestion, cough, headache. Positive again on home rapid test.; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Testing positive for covid again, possible rebound after taking paxlovid. Sore throat, congestion, cough, headache. Positive again on home rapid test.) in a 34-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product NIRMATRELVIR, RITONAVIR (PAXLOVID) for COVID-19.    Concurrent medical conditions included Hashimoto's disease and Allergy. Concomitant products included LEVOTHYROXINE SODIUM (LEVOTHYROXIN) for an unknown indication.   On 05-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Apr-2022, the patient started NIRMATRELVIR, RITONAVIR (PAXLOVID) (unknown route) at an unspecified dose. On 14-May-2022, the patient experienced COVID-19 (Testing positive for covid again, possible rebound after taking paxlovid. Sore throat, congestion, cough, headache. Positive again on home rapid test.). At the time of the report, COVID-19 (Testing positive for covid again, possible rebound after taking paxlovid. Sore throat, congestion, cough, headache. Positive again on home rapid test.) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-2 test: positive (Positive) Positive.         It was reported that testing positive for covid again, possible rebound after taking paxlovid. Sore throat, congestion, cough and headache. Positive again on home rapid test with the onset date of 14-MAY-2022 and outcome as not recovered.  Device date was reported as 15-May-2022  It  was reported that patient took other medications within 2 weeks of starting COVID-19 treatment.  Company comment- This spontaneous case concerns a 34-year-old female patient with no relevant medical history, who experienced the unexpected non-serious adverse event of special interest COVID-19 (with a positive SARS-CoV-2 test) that occurred 6 months and 9 days after receiving the third dose of mRNA-1273 Vaccine.  After taking paxlovid, the patient tested positive for Covid-19 again using a home rapid test with symptoms of sore throat, congestion, cough and headache Outcome of the events was not resolved at the time of this report. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.; Sender's Comments: This spontaneous case concerns a 34-year-old female patient with no relevant medical history, who experienced the unexpected non-serious adverse event of special interest COVID-19 (with a positive SARS-CoV-2 test) that occurred 6 months and 9 days after receiving the third dose of mRNA-1273 Vaccine.  After taking paxlovid, the patient tested positive for Covid-19 again using a home rapid test with symptoms of sore throat, congestion, cough and headache Outcome of the events was not resolved at the time of this report. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.